These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. Zhao XJ, Li H, Chen H, Liu YX, Zhang LH, Liu SX, Feng QL. World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436 [Abstract] [Full Text] [Related]
3. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S. Oncology; 1997 Feb; 54(2):158-65. PubMed ID: 9075789 [Abstract] [Full Text] [Related]
4. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray. Peng H, Zhong XY, Liu KP, Li SM. Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414 [Abstract] [Full Text] [Related]
5. Expression of e-cadherin and catenins in early gastric cancer. Joo YE, Rew JS, Choi SK, Bom HS, Park CS, Kim SJ. J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224 [Abstract] [Full Text] [Related]
10. Accumulation of cytoplasmic beta-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Zhang G, Zhou X, Xue L, Quan L, Wang Y, Zhou C, Lu N, Wang Q, Zhu H, Xu N. Pathol Int; 2005 Jun; 55(6):310-7. PubMed ID: 15943787 [Abstract] [Full Text] [Related]
11. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer. Ishiguro H, Wakasugi T, Terashita Y, Sakamoto N, Tanaka T, Mizoguchi K, Sagawa H, Okubo T, Takeyama H. World J Surg Oncol; 2016 Sep 06; 14(1):240. PubMed ID: 27600761 [Abstract] [Full Text] [Related]
15. E-cadherin and catenins in early squamous cervical carcinoma. Van de Putte G, Kristensen GB, Baekelandt M, Lie AK, Holm R. Gynecol Oncol; 2004 Aug 06; 94(2):521-7. PubMed ID: 15297198 [Abstract] [Full Text] [Related]
16. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin]. Tamura S, Shiozaki H, Kadowaki T, Inoue M, Oka H, Matsui S, Mori T. Nihon Geka Gakkai Zasshi; 1995 Aug 06; 96(8):550-6. PubMed ID: 7565577 [Abstract] [Full Text] [Related]
17. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC, Lee MS. Oncol Rep; 2002 Aug 06; 9(5):915-28. PubMed ID: 12168049 [Abstract] [Full Text] [Related]
19. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma. Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC. Br J Dermatol; 2001 Oct 06; 145(4):582-9. PubMed ID: 11703284 [Abstract] [Full Text] [Related]